Valuation: North China Pharmaceutical Company.Ltd

Market Cap 7.88B 1.17B 1.02B 961M 870M 1.63B 112B 1.64B 11.46B 4.41B 57.04B 4.41B 4.31B 182B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.55B 2.61B 2.26B 2.14B 1.94B 3.64B 251B 3.66B 25.54B 9.83B 127B 9.82B 9.6B 405B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
40.58%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-6.71%
1 week-2.55%
Current month-4.18%
1 month-8.93%
3 months+2.46%
6 months-19.33%
Current year-17.00%
1 week 4.59
Extreme 4.59
5.28
1 month 4.56
Extreme 4.56
5.28
Current year 4.11
Extreme 4.11
6.07
1 year 4.11
Extreme 4.11
6.29
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 28/11/2025
Director of Finance/CFO 46 10/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 22/03/2016
Chairman 54 10/04/2023
Director/Board Member 53 23/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
25/02/25 Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-6.71%-2.55%-23.88%-16.70% 1.26B
-0.19%+1.09%+51.85%+97.36% 1,015B
+0.33%-0.71%+50.62%+65.50% 642B
+0.49%+5.73%+20.88%+72.92% 463B
-0.22%+1.98%+36.33%+38.93% 353B
-0.07%-9.26%+15.16%+24.78% 265B
-0.31%+0.61%+2.73%+12.04% 254B
-1.53%-4.46%+36.90%+44.08% 206B
-1.60%-7.71%-20.79%-59.60% 191B
+0.49%-0.23%+30.00%+93.34% 182B
Average -1.00%-3.46%+19.98%+37.27% 357.15B
Weighted average by Cap. -0.28%-2.21%+33.97%+59.50%

Financials

2024 2025
Net sales 9.87B 1.47B 1.27B 1.2B 1.09B 2.05B 141B 2.06B 14.37B 5.53B 71.49B 5.52B 5.4B 228B 9.24B 1.38B 1.19B 1.13B 1.02B 1.92B 132B 1.93B 13.45B 5.18B 66.94B 5.17B 5.05B 213B
Net income 127M 18.91M 16.38M 15.49M 14.02M 26.32M 1.81B 26.52M 185M 71.11M 920M 71.04M 69.46M 2.93B 183M 27.26M 23.61M 22.33M 20.21M 37.94M 2.61B 38.22M 266M 103M 1.33B 102M 100M 4.23B
Net Debt 9.79B 1.46B 1.26B 1.19B 1.08B 2.03B 140B 2.04B 14.25B 5.48B 70.91B 5.48B 5.35B 226B 9.67B 1.44B 1.25B 1.18B 1.07B 2B 138B 2.02B 14.08B 5.42B 70.07B 5.41B 5.29B 223B
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
15/09/26 CN¥4.590 -6.71% 58,553,590
14/09/26 CN¥4.920 -0.40% 68,352,353
11/09/26 CN¥4.940 -4.63% 105,335,050
10/09/26 CN¥5.180 +7.92% 112,742,043
09/09/26 CN¥4.800 -1.44% 14,744,354

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600812 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!